ChartRow logo
Data provided bySource: Twelve Data
PeersSOLVCOOBAXAVTRRGENSPY
Share this page

ALGN — Align Technology Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in ALGN be worth today? →
ALGN returns: By year · By month · By week · Trailing

Price data

Price
$166.00
YTD price return
+6.31%
YTD total return
+6.31%
Market cap
11.7B
Enterprise value
10.7B
Shares outstanding
70.5M
52W low
$130.23
52W high
$200.44
From 52W high
-17.18%
From 52W low
+27.47%
52W range
51%$130–$200
Beta
1.64

Volume

Rel volume
1.68×
30D volume
1M
30D $ vol
157.3M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
none
Insider net 1Y
−$1.5M

Form 4 transactions by trade date, as filed; latest on file 2026-02-18.

Fundamentals

Sales (ttm)
4.2B
Sales/share
$59.00
EPS (ttm)
$6.88
FCF (ttm)
602.5M
FCF/share
$8.55
Book value/share
$61.08
Net margin
11.83%
ROE
11.42%
ROA
7.54%
Current ratio
1.42

Growth (CAGR, ttm) · 10Y

Sales
+4.42%+2.99%+2.06%+15.13%
Net income
+30.01%+10.67%-7.85%+9.93%
FCF
+6.33%-4.24%-8.43%+13.30%
Shares
-1.76%-2.73%-2.22%-1.22%

Per-share growth (CAGR, ttm) · 10Y

EPS
+33.33%+13.50%-5.82%+11.36%
Sales/share
+6.29%+5.88%+4.37%+16.55%
FCF/share
+8.24%-1.55%-6.36%+14.70%
Book value/share
+10.75%+7.16%+6.49%+17.48%
Price
+24.15%-5.67%-24.72%+6.83%
Total return
+24.15%-5.67%-24.72%+6.83%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
24.1×
P/OI (ttm)
18.9×
Fwd P/E
14.0×
P/S (ttm)
2.8×
P/B (mrq)
2.7×
P/FCF (ttm)
19.4×
EV/EBITDA (fy)
12.5×
EV/Sales (ttm)
2.6×
FCF yield (ttm)
5.15%
Buyback yield (realized, 1y)
1.76%
Shareholder yield (realized, 1y)
1.76%
Buyback yield (cash, ttm)
2.38%
Shareholder yield (cash, ttm)
2.38%

Vs own 10Y history

P/E
11th
P/OI
5th
P/S
6th
P/B
6th
P/FCF
7th

Bar = where today’s multiple sits in ALGN’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+4.16%
5D
+10.75%
1M
+17.36%
3M
-1.82%
YTD
+6.31%
1Y
+24.13%
5Y
-75.84%
1D
+4.16%
5D
+10.75%
1M
+17.36%
3M
-1.82%
YTD
+6.31%
1Y
+24.13%
5Y
-75.84%

Fundamentals#

Revenue

5Y CAGR +10.3%10Y CAGR +16.9%YoY +1.9%
$4.2B TTM$1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +7.1%10Y CAGR +11.2%YoY +75.7%
$620.5M TTM$169.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR −24.1%10Y CAGR +12.3%YoY +143.6%
$6.88 TTM$1.90 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −0.7%10Y CAGR +10.3%YoY −18.4%
$602.5M TTM$137.9M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $749.9M, capex −$147.4M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $182.9M, capex −$45M

Shares (diluted)

5Y −8.4%10Y −11.0%YoY −1.9%
71.5M TTM71M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −25.4%10Y CAGR +11.0%YoY +138.0%
$491.9M TTM$135M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full ALGN financials →

Align Technology Inc. is a medical device company focused on digital orthodontics and restorative dentistry. The company develops and markets the Invisalign clear aligner system, Vivera retainers, and a range of intraoral scanning and digital treatment-planning tools used by dental professionals. Its iTero scanners and related services support precise imaging, workflow efficiency, and chairside communication in orthodontic and general dentistry practices. Align Technology also offers exocad CAD/CAM software, extending its presence across dental design and fabrication workflows. The company serves dentists, orthodontists, and dental laboratories in markets around the world, with products designed to support treatment planning, patient monitoring, and restorative procedures. Align Technology plays a central role in the shift from traditional braces and analog dental processes to connected, software-enabled oral healthcare solutions.

Tempe, AZ·20,435 employees·Medical Instruments & Supplies·aligntech.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding ALGN#

28 of the 193 ETFs ChartRow carries live hold ALGN. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VBRVanguard Small-Cap Value ETF0.2%
XLVHealth Care Select Sector SPDR Fund0.2%
RSPInvesco S&P 500 Equal Weight ETF0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
SPYVSPDR Portfolio S&P 500 Value ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%